Sequent Scientific Limited
has completed transaction on proposed acquisition of 15% stake from Servatius Justinus Cornelius Maria Van Der Heijden in Fendigo BV through Alivira Animal Health Limited, Ireland, Wholly Owned Subsidiary of the company.
“On completion of the said transaction, Fendigo BV has become a Wholly Owned Subsidiary of the company,” company informed the exchanges on Friday.
Sequent Scientific ended at Rs155.40, down by Rs3 or 1.89% from its previous closing of Rs158.40 on the BSE.
The scrip opened at Rs161.75 and has touched a high and low of Rs162.70 and Rs154.50 respectively.